Breast cancer (Tokyo, Japan)最新文献

{"title":"Three cases of whole breast irradiation for breast cancer in patients with Lymphangioleiomyomatosis (LAM).","authors":"Rumiko Kinoshita, Mitsuchika Hosoda, Fumi Kato, Hirokazu Kimura, Kaoruko Shimizu, Takashi Mori, Kentaro Nishioka, Takayuki Hashimoto, Masato Takahashi, Satoshi Konno, Hidefumi Aoyama","doi":"10.1007/s12282-026-01839-2","DOIUrl":"10.1007/s12282-026-01839-2","url":null,"abstract":"","PeriodicalId":520574,"journal":{"name":"Breast cancer (Tokyo, Japan)","volume":" ","pages":"784-789"},"PeriodicalIF":2.9,"publicationDate":"2026-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147346220","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Quality of life in women with breast cancer undergoing chemotherapy: a comparative cross-sectional study of CICC ports and PICC-ports.","authors":"Marco Soldani, Daniele Privitera, Chiara Caradonna, Giuseppe Papagni, Elif Akyüz, Nicolò Capsoni, Chiara Airoldi, Davide Giustivi","doi":"10.1007/s12282-026-01843-6","DOIUrl":"10.1007/s12282-026-01843-6","url":null,"abstract":"","PeriodicalId":520574,"journal":{"name":"Breast cancer (Tokyo, Japan)","volume":" ","pages":"666-674"},"PeriodicalIF":2.9,"publicationDate":"2026-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147483123","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Fear of diagnosis as a barrier to the screening and diagnosis of breast cancer.","authors":"Anya Mantripragada, Sydney Vaughn, Latha Ganti","doi":"10.1007/s12282-026-01845-4","DOIUrl":"10.1007/s12282-026-01845-4","url":null,"abstract":"","PeriodicalId":520574,"journal":{"name":"Breast cancer (Tokyo, Japan)","volume":" ","pages":"683-692"},"PeriodicalIF":2.9,"publicationDate":"2026-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147629717","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"UGT2B17 as a predictive biomarker of complete pathological response in HER2 + breast cancer.","authors":"Ana Gil-Torralvo, M Ángeles Domínguez-Cejudo, Sonia Molina-Pinelo, Carmen Garrigós, Marta Benavent-Viñuales, Alejandro Falcón, Mónica Cejuela, Beatriz Rodríguez-Alonso, Javier Pascual, Manuel Ruíz-Borrego, Javier Salvador-Bofill","doi":"10.1007/s12282-026-01840-9","DOIUrl":"10.1007/s12282-026-01840-9","url":null,"abstract":"","PeriodicalId":520574,"journal":{"name":"Breast cancer (Tokyo, Japan)","volume":" ","pages":"634-643"},"PeriodicalIF":2.9,"publicationDate":"2026-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13124799/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147367844","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Integration of gene expression profiling and mutation analysis via RNA sequencing: transitioning the 95-gene classifier to a next-generation platform in early-stage HR+/HER2- breast cancer.","authors":"Chikage Kato, Yoshiaki Sota, Sae Kitano, Akira Watanabe, Maiko Nishida, Daitho Motonari, Yuria Saito, Masaki Kobayashi, Midori Morita, Koichi Sakaguchi, Kenzo Shimazu, Yasuto Naoi","doi":"10.1007/s12282-026-01854-3","DOIUrl":"10.1007/s12282-026-01854-3","url":null,"abstract":"","PeriodicalId":520574,"journal":{"name":"Breast cancer (Tokyo, Japan)","volume":" ","pages":"722-735"},"PeriodicalIF":2.9,"publicationDate":"2026-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147597351","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Beyond the triad: biological subtypes and the \"safety net\" in omitting sentinel lymph node biopsy.","authors":"Bin Ye, Bo Ma","doi":"10.1007/s12282-026-01848-1","DOIUrl":"10.1007/s12282-026-01848-1","url":null,"abstract":"","PeriodicalId":520574,"journal":{"name":"Breast cancer (Tokyo, Japan)","volume":" ","pages":"798-799"},"PeriodicalIF":2.9,"publicationDate":"2026-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147648706","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Targeting breast cancer senescence in 3D models of bone metastasis.","authors":"Eleane C B Hamburger, Mansoureh Mohseni Garakani, Saber Ghazizadeh, Saleh Alfaisali, Jean A Ouellet, Michael H Weber, Livia Garzia, Lisbet Haglund, Derek H Rosenzweig","doi":"10.1007/s12282-026-01857-0","DOIUrl":"10.1007/s12282-026-01857-0","url":null,"abstract":"","PeriodicalId":520574,"journal":{"name":"Breast cancer (Tokyo, Japan)","volume":" ","pages":"770-783"},"PeriodicalIF":2.9,"publicationDate":"2026-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147648763","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Characteristics of a multigene assay (MammaPrint/Blueprint) to predict early recurrence of hormone receptor-positive, HER2-negative breast cancer: a case‒control study (WJOG16722B).","authors":"Rurina Watanuki, Hitomi Sakai, Yuri Kimura, Atsushi Yoshida, Yukinori Ozaki, Akemi Kataoka, Natsue Uehiro, Atsushi Fushimi, Hidenori Kamio, Takashi Ikeno, Masashi Wakabayashi, Mayumi Iida, Tsutomu Kawaguchi, Junji Tsurutani, Toshimi Takano","doi":"10.1007/s12282-026-01847-2","DOIUrl":"10.1007/s12282-026-01847-2","url":null,"abstract":"<p><strong>Background: </strong>Hormone receptor-positive, HER2-negative (HR + /HER2-) breast cancer generally has a favorable prognosis; however, early postoperative recurrence markedly reduces survival. Accurate prediction of early recurrence is crucial for personalizing treatment. This case-control study compared MammaPrint (MP) and BluePrint (BP) results between early recurrence patients and matched controls.</p><p><strong>Methods: </strong>Patients were selected from our previous study, the WJOG15721B cohort (n = 2732). Those with recurrence within three years after surgery were randomly extracted, and controls matched for institution, clinical stage, and number of pathological lymph node metastases were included (n = 124). Tumor samples underwent MP and BP assays to classify recurrence risk and molecular subtypes.</p><p><strong>Results: </strong>Of 115 submitted tumor samples, 85 were analyzed successfully (43 early recurrence, 42 no recurrence). High-risk MP classification was significantly more frequent in early recurrence patients (79.1% vs. 40.5%, p < 0.001), and Luminal B BP subtype was more common in early recurrence patients (79.1% vs. 38.1%, p < 0.001). High MP risk was associated with high Ki-67 levels and higher nuclear grade. Integrating clinical and genomic risk enhanced prognostic precision: patients with both clinical and genomic high risk had the highest recurrence rate (100%), those with low clinical and genomic risk had the lowest (28.1%), and patients with low clinical but high genomic risk showed an intermediate recurrence rate (57.5%).</p><p><strong>Conclusions: </strong>Compared with patients without recurrence, those with early recurrence showed a significantly higher prevalence of high-risk MP results and Luminal B BP subtype. High-risk MP/Luminal B BP subtype suggested an association with early recurrence in patients with HR + /HER2- early breast cancer.</p>","PeriodicalId":520574,"journal":{"name":"Breast cancer (Tokyo, Japan)","volume":" ","pages":"693-704"},"PeriodicalIF":2.9,"publicationDate":"2026-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13124841/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147523810","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Time-dependent diffusion MRI for non-invasive differentiation of benign and malignant breast lesions and evaluation of proliferation index biomarkers.","authors":"Luqing Ru, Yanlin Tang, Jigeng Zhang, Ran Shi, Dawei Yin, Yong Zhang, Yuan Kong, Jun Du, Peng Wang","doi":"10.1007/s12282-026-01842-7","DOIUrl":"10.1007/s12282-026-01842-7","url":null,"abstract":"","PeriodicalId":520574,"journal":{"name":"Breast cancer (Tokyo, Japan)","volume":" ","pages":"653-665"},"PeriodicalIF":2.9,"publicationDate":"2026-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147438849","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Low-progesterone receptor expression predicts nodal pathological complete response after neoadjuvant chemotherapy in premenopausal patients with ER-positive/HER2-negative breast cancer.","authors":"Naoko Iwamoto, Shin-Ichiro Horiguchi, Takashi Kuwayama, Masakazu Toi","doi":"10.1007/s12282-026-01851-6","DOIUrl":"10.1007/s12282-026-01851-6","url":null,"abstract":"","PeriodicalId":520574,"journal":{"name":"Breast cancer (Tokyo, Japan)","volume":" ","pages":"744-751"},"PeriodicalIF":2.9,"publicationDate":"2026-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147629691","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}